F

FibroGen

487 employees

FibroGen uses its expertise in CTGF and HIF biology to discover, develop, and commercialize novel therapeutics.

Basic info

Industry

biotechnology research

Sectors

Anti-CTGF
Biotechnology
Anemia
Idiopathic Pulmonary Fibrosis
Chronic Kidney Disease
Pancreatic Cancer
HIF-PHI
Health Care
Fibrotic Disease
Therapeutics
Biopharma
Duchenne Muscular Dystrophy

Date founded

1993

FAQ